New GCB Core engages in microbiome profiling

Woman standing by scientific equipment
GCB News

New GCB Core engages in microbiome profiling

GCB is excited to announce the creation of its fifth core facility. The Microbiome Shared Resource (MSR) will serve as a centralized hub to enhance existing interactions with the Duke Microbiome Center, the Duke Cancer Institute and the Genomic Analysis and Bioinformatics shared resource to address the role of microbial systems in human healthcare, food production and environmental restoration.

MSR will provide access to a variety of services that enable researchers the ability to focus on microbial communities (bacteria, fungi and virus), immune oncology, cancer research and infectious disease.

“By partnering with other Duke resources,” said MSR director Holly Dressman, “we are excited to provide the research community a comprehensive range of services that will help enhance microbiome research from the onset of experimental design through data analysis support.”

Through their support from the Duke Microbiome Center, investigators will also benefit from the intellectual and educational environment that will enable a collaborative research environment.

Visit the Microbiome Shared Resource to learn more about their services. The core is located in 2208B CIEMAS.

Related News

Dr. Beth Sullivan and Naeema Hopkins-Kotb next to scientific poster

Summer springs into fall opportunity

Students interested in careers in genome sciences and medicine need a strong foundation of core genome sciences, technology and interdisciplinary training.
view
picture collage with images from four different Bass Connections Projects plus a picture of Duke Campus

Bass Connections Annual Report Out Now

Bass Connections released their

view
A graphical abstract of how the team uses epigenomic editing to downregulate SNCA genes

Targeted epigenome editing as ‘next generation drugs’ for Parkinson’s disease

By 2020, the Parkinson’s Foundation estimates that nearly one million people will be living with Parkinson’s disease in the U.S.
view